Characteristics of pulmonary mucormycosis and the experiences of surgical resection

被引:8
|
作者
Shao, Weipeng [1 ,2 ]
Zhang, Jun [1 ,2 ]
Ma, Shanwu [1 ,2 ]
Feng, Hongxiang
Zhang, Zhenrong
Liang, Chaoyang
Liu, Deruo [1 ,2 ]
机构
[1] Peking Univ, China Japan Friendship Sch Clin Med, Dept Gen Thorac Surg, 2 Yinghua,East Rd, Beijing 100029, Peoples R China
[2] China Japan Friendship Hosp, 2 Yinghua,East Rd, Beijing 100029, Peoples R China
关键词
Pulmonary mucormycosis (PM); surgery; operation time; blood loss; AMPHOTERICIN-B; TRANSPLANT RECIPIENTS; INVASIVE ZYGOMYCOSIS; ANTIFUNGAL THERAPY; UPDATE; ASPERGILLOSIS; EPIDEMIOLOGY; PATHOGENESIS; MANAGEMENT; DISEASES;
D O I
10.21037/jtd.2019.12.117
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Pulmonary mucormycosis (PM) is a relatively rare but fatal infection. However, detailed surgery data have been lacking. We summarized the characteristics of this rare disease and clarified the experiences of surgical resection Methods: We conducted a single-center retrospective study of seven patients with PM who underwent surgical resection at China-Japan Friendship Hospital from May 2011 to May 2018. Results: Patient ages ranged from 18 to 70 years, with a median age of 47 years. Manual workers (85.7%) were the most common occupation and their educational level was also below high school. Diabetes was the most common underlying condition. The most common radiographic finding was lobar consolidation. Three patients directly underwent open thoracotomy, one patient underwent video-assisted thoracic surgery (VATS) and three patients converted from VATS to thoracotomy. The median operation time was 240 min [interquartile range (IQR), 150-390 min], the median intraoperative blood loss was 500 mt. (IQR, 100-1,200 mL) and the median intraoperative blood transfusion was 600 mL (IQR, 0-1,600 mL). In-hospital, 90-day, 1-year and 5-year mortality were 14.3%, 14.3%, 28.8% and 42.9%, respectively. Conclusions: PM is a rare but fatal infection. Due to chest adhesion and vascular invasion, the proportion of massive bleeding and long operation time has increased sharply.
引用
收藏
页码:733 / 740
页数:8
相关论文
共 50 条
  • [11] SURGICAL RESECTION OF PULMONARY METASTASES
    MCCORMACK, P
    SEMINARS IN SURGICAL ONCOLOGY, 1990, 6 (05): : 297 - 302
  • [12] Surgical resection of pulmonary metastases
    Cheng, LC
    Chiu, CSW
    Lee, JWT
    JOURNAL OF CARDIOVASCULAR SURGERY, 1998, 39 (04): : 503 - 507
  • [13] COVID associated pulmonary mucormycosis: Outcomes of surgical therapy
    Pulle, Mohan Venkatesh
    Bishnoi, Sukhram
    Asaf, Belal Bin
    Puri, Harsh Vardhan
    Deshwal, Vikas
    Kumar, Arvind
    ASIAN CARDIOVASCULAR & THORACIC ANNALS, 2023, 31 (02): : 133 - 141
  • [14] EXPERIENCES IN THE MANAGEMENT OF PULMONARY MUCORMYCOSIS FROM A UNIVERSITY TEACHING HOSPITAL
    Subramaniam, Sobha
    Paul, Tisa
    Mehta, Asmita
    CHEST, 2020, 158 (04) : 2474A - 2474A
  • [15] FURTHER EXPERIENCES IN PULMONARY RESECTION IN THE TREATMENT OF PULMONARY TUBERCULOSIS
    OVERHOLT, RH
    SURGERY, 1947, 21 (01) : 148 - 149
  • [16] Outcomes after lung resection in renal transplant patients with pulmonary mucormycosis
    Seth, Abhinav
    Patil, Shivakumar S.
    Axelrod, David
    Singh, Harkant
    Sharma, Ashish
    Kenwar, Deepesh Benjamin
    Vaiphei, Kim
    Mandwar, Milind
    Rally, Sahil
    Singh, Sarbpreet
    CLINICAL TRANSPLANTATION, 2022, 36 (07)
  • [17] Commentary: Pneumonectomy for resection of pulmonary mucormycosis: Enough is never too much
    Merritt, Robert E.
    JTCVS TECHNIQUES, 2022, 11 : 87 - 88
  • [18] Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome
    Jun Feng
    Xuefeng Sun
    Infection, 2018, 46 : 503 - 512
  • [19] Surgical Management of Pulmonary Mucormycosis in Third-Trimester Pregnancy
    Ramirez, Joel L.
    Urisman, Anatoly
    Kukreja, Jasleen
    Kratz, Johannes R.
    THORACIC AND CARDIOVASCULAR SURGEON REPORTS, 2018, 7 (01): : E27 - E29
  • [20] Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome
    Feng, Jun
    Sun, Xuefeng
    INFECTION, 2018, 46 (04) : 503 - 512